Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 46,300
+1,300 (2.89%)
Aug 11, 2026, 12:00 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 1.99 trillion as of August 10, 2026. Its market cap has decreased by -13.53% in one year.
Market Cap
1.99T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
77.14
Stock Price
46,300.00
ChartMarket Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 1.99T, an increase of 2,897.75%. That is a compound annual growth rate of 18.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 1.99T | -22.68% |
| Dec 30, 2025 | 2.57T | 4.33% |
| Dec 30, 2024 | 2.47T | -35.41% |
| Dec 28, 2023 | 3.82T | 44.48% |
| Dec 29, 2022 | 2.64T | -43.45% |
| Dec 30, 2021 | 4.67T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 6.01T |
| Hanmi Pharm. | 4.98T |
| Hanall Biopharma | 2.75T |
| Daewoong Pharmaceutical | 1.48T |
| GC Biopharma | 1.48T |
| Chong Kun Dang Pharmaceutical | 928.91B |
| DongKook Pharmaceutical | 870.64B |
| Daewoong | 754.14B |